You are here: Home » PTI Stories » National » News
Business Standard

Vivimed Labs Alathur unit completes successful USFDA visit

Press Trust of India  |  New Delhi 

Drug firm today said the US health regulator has completed the inspection of its manufacturing facility in Alathur.

The company's 'Finished Dosage Form' manufacturing facility has had a favourable outcome post its US Food and Drug Administration (USFDA) inspection, said in a filing to BSE.



The audit was conducted during the last week of November and concluded on November 28, 2016, it added.

Commenting on the development, MD Santosh Varalwar said: "Over the two years we have received satisfactory outcomes of USFDA inspections for our two plants in Spain, one in Mexico and one in India."

For the plant, this was the second inspection, he added.

"We believe that this satisfactory outcome will support our endeavour to further strengthen our positioning in the global markets," Varalwar said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Vivimed Labs Alathur unit completes successful USFDA visit

Drug firm Vivimed Labs today said the US health regulator has completed the inspection of its manufacturing facility in Alathur. The company's 'Finished Dosage Form' manufacturing facility has had a favourable outcome post its US Food and Drug Administration (USFDA) inspection, Vivimed Labs said in a filing to BSE. The audit was conducted during the last week of November and concluded on November 28, 2016, it added. Commenting on the development, Vivimed Labs MD Santosh Varalwar said: "Over the two years we have received satisfactory outcomes of USFDA inspections for our two plants in Spain, one in Mexico and one in India." For the India plant, this was the second inspection, he added. "We believe that this satisfactory outcome will support our endeavour to further strengthen our positioning in the global markets," Varalwar said. Drug firm today said the US health regulator has completed the inspection of its manufacturing facility in Alathur.

The company's 'Finished Dosage Form' manufacturing facility has had a favourable outcome post its US Food and Drug Administration (USFDA) inspection, said in a filing to BSE.

The audit was conducted during the last week of November and concluded on November 28, 2016, it added.

Commenting on the development, MD Santosh Varalwar said: "Over the two years we have received satisfactory outcomes of USFDA inspections for our two plants in Spain, one in Mexico and one in India."

For the plant, this was the second inspection, he added.

"We believe that this satisfactory outcome will support our endeavour to further strengthen our positioning in the global markets," Varalwar said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Vivimed Labs Alathur unit completes successful USFDA visit

Drug firm today said the US health regulator has completed the inspection of its manufacturing facility in Alathur.

The company's 'Finished Dosage Form' manufacturing facility has had a favourable outcome post its US Food and Drug Administration (USFDA) inspection, said in a filing to BSE.

The audit was conducted during the last week of November and concluded on November 28, 2016, it added.

Commenting on the development, MD Santosh Varalwar said: "Over the two years we have received satisfactory outcomes of USFDA inspections for our two plants in Spain, one in Mexico and one in India."

For the plant, this was the second inspection, he added.

"We believe that this satisfactory outcome will support our endeavour to further strengthen our positioning in the global markets," Varalwar said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard